Search Results

Celdara Medical, LLC (Celdara), an experienced biopharma developer focused on launching promising products for the patients who need them most, today announced a new strategic collaboration with the Global Virus Network (GVN),

Celdara Medical (“Celdara”) today announced the launch of its Pandemic Security Initiative, harnessing the resources needed to prepare the nation for future infectious disease pandemics.

Grant Enables Development of Innovative Medicines Against Future Pandemic Threats [12-August-2020] CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Aug. 12, 2020 /PRNewswire/ -- Celdara Medical (“Celdara”) announced that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Small Business Innovatio

Celdara Medical, LLC announced that the National Institute of Allergy and Infectious Disease of the National Institutes of Health has awarded it a two-year Small Business Technology Transfer Research grant to fund the development of a novel, broad-spectrum therapeutic/prophylactic against RNA viruses, including SARS-CoV-2, SARS, Ebola, influenza, and pathogenic arenaviruses.

Quantify Medical Sees Initial Success with Venowave VW5 Sales and Medicare/Medicaid Reimbursement Test

The Dana Foundation Launches Neurotech Justice Accelerator at Mass General Brigham (NJAM) to Unite Science and Society and Mitigate Medical, Legal, and Ethical Risks